Roscovitine inhibits ongoing DNA synthesis in human cervical cancer

Cancer Letters

Volumn 180, Issue 1, 2002, Pages 7-12

  Vitali, Liliana ^a,e   Yakisich, J Sebastian ^b,c   Vita, Marina Fernanda ^a   Fernandez, Alejandro ^d   Settembrini, Liliana ^d   Siden, Åke ^c   Cruz, Mabel ^b   Carminatti, Hector ^a   Casas, Oscar ^e   Idoyaga Vargas, Victor ^a  

^a FUNDACIÓN INSTITUTO LELOIR   (Argentina)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d Hospital Maria Curie   (Argentina)

^e Instituto de Terapia Radiante   (Argentina)

Author keywords

Cervical cancer; Cyclin dependent kinases; DNA synthesis; Roscovitine

Indexed keywords

ROSCOVITINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CELL PROLIFERATION; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS; DNA SYNTHESIS INHIBITION; DRUG EFFECT; FEMALE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CYCLIN-DEPENDENT KINASES; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMALE; HUMANS; MIDDLE AGED; PURINES; TIME FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 18344377661     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(01)00827-8     Document Type: Article

References (29)

1. Estimates of the worldwide incidence of 18 major cancers in 1985
2. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer
3. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma
4. Clinical dose-response curves of human malignant epithelial tumours
5. Hydroxyurea or placebo combined with radiation to treat stages IIIB and IV cervical cancer confined to the pelvis
6. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer
7. Vaginal changes and sexuality in women with a history of cervical cancer
8. Biochemical and cellular effect of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5
9. The effect of the cyclin-dependent kinase inhibitor olomoucine on cell cycle kinetics
10. Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with Roscovitine, a novel cyclin-dependent kinase antagonist
11. Chemical inhibitors of cyclin-dependent kinases
12. Inhibition of DNA synthesis in human gliomas by roscovitine
13. Underexpression of cyclin-dependent kinase (CDK) inhibitors in cervical carcinoma
14. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions
15. Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein
16. The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2
17. Fast and sensitive method for simultaneous measurement of cell proliferation rate and drug sensitivity in rat cerebral cortex
18. Early inhibition of DNA synthesis in the developing rat cerebral cortex by the purine analogues olomoucine and roscovitine
19. Intracellular targets of cyclin-dependent kinase inhibitors: Identification by affinity chromatography using immobilised ligands
20. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective
21. Papillomavirus infections - A major cause of human cancers
22. Viral oncogenes accelerates conversion to immortality of cultured conditionally immortal human mammary epithelial cells
23. Overriding of cyclin-dependent kinase inhibitors by high and low risk human papillomavirus types: Evidence for an in vivo role in cervical lesions
24. The human papillomavirus type 16 E6 and E/ oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell cycle
25. Human papillomavirus type 16 E7 oncoprotein-induced abnormal centrosome synthesis is an early event in the evolving malignant phenotype
26. Transcripcion of herpes simplex virus immediate-early and early genes is inhibited by roscovitine, an inhibitor specific for cellular cyclin-dependent kinases
27. Requirement for cellular cyclin-dependent kinase in herpes simplex virus replication and transcription
28. Inhibition of cellular Cdk2 activity blocks human cytomegalovirus replication
29. Inhibition of human immunodeficiency virus type 1 transcription by chemical cyclin-dependent kinase inhibitors